Sacubitril (49mg), Valsartan (51mg)
Feb 03, 2023
SACUBRIGHT 100
Sacubitril (49mg), Valsartan (51mg)
Sacubitril/valsartan, the first angiotensin receptor neprilysin inhibitor approved by the Food and Drug Administration for marketing, has been shown to reduce the risk of cardiovascular death or heart failure hospitalization and improve symptoms in patients with chronic heart failure with a reduced ejection fraction.
For further information please contact: info@sterispharma.com
Recent Post
Combipack of Mirabegron Extended Release 25 mg & Silodosin 8 mg ,.,,.
Hydrochlorothiazide (25mg) ,...,
Tamoxifen IP 20mg""''"''
Hydrochlorothiazide (12.5mg) ,.,,,
Tamoxifen IP 10mg"'''"'"
Prazosin (2mg) ,.,,,
Fluticasone Fur .(27.5mcg), Azelastine (140mcg) '''''
Glycopyrrolate and formoterol fumarate powder for inhalation""''"''
(10mg) Medroxyprogesterone '''''
Prazosin (1mg) ,.,,